Background. American cutaneous leishmaniasis is considered to be a zoonotic disease transmitted by sand flies that feed on infected sylvatic mammals. However, the "domestication" of transmission and the increase in treatment failure with antimonial drugs have raised the suspicion of anthroponotic transmission of American cutaneous leishmaniasis.
palpis, a surrogate vector of Leishmania (Viannia) parasites, could acquire infection when fed on the border of dermal lesions from patients with active disease [13, 14] . In addition, Leishmania kinetoplast DNA has been detected by polymerase chain reaction (PCR) in healed lesions several years after treatment and in peripheral blood in the absence of active disease [15, 16] , and parasites have been isolated from healed lesions [17] . These findings-and the demonstration of reactivation as a cause of recurrent episodes of cutaneous leishmaniasis [18] substantiate the persistence of L. (Viannia) parasites in previously affected skin sites and blood in the absence of disease. However, the epidemiological significance of persistent subclinical infection by dermotrophic Leishmania parasites is unknown.
We conducted the present study to determine whether Leishmania parasites are present in sites and tissues of infected humans that are accessible to sand flies seeking a blood meal. Furthermore, we sought to determine whether Leishmania prevalence in these tissues would be altered by treatment.
MATERIALS AND METHODS
Study design. An exploratory study was conducted to establish thresholds of frequency, presumptively demarcating the biological relevance of Leishmania parasites in tissues accessible to sand flies. The sample size was calculated to be 49 subjects, with an expected prevalence of the phenomenon of 15%, a precision of 10%, and a significance level of 5%. This number was increased by 20% to 59 subjects, to account for potential losses due to incomplete or inadequate samples and patient attrition.
Patients who received standard pentavalent Sb (Sb   V   ) treatment and participated in the pretreatment procedures to detect Leishmania parasites were invited to participate in the repeat of those procedures у13 weeks after the initiation of treatment.
The study protocol and informed consent were approved by the Centro Internacional de Entrenamiento e Investigaciones Medicas (CIDEIM) Institutional Review Board for the protection of human subjects from research risks and were in accordance with the guidelines of the Declaration of Helsinski, good clinical practice, and the Colombian Ministry of Social Protection (Resolution 8430; . Written, informed consent was obtained from all participants or their parents or guardians after the explanation of study procedures, potential benefits and risks, and the voluntary nature of participation.
Inclusion and exclusion criteria. Patients who had parasitologically confirmed cutaneous leishmaniasis of р3 months of evolution and who were у16 years of age were eligible to participate. Patients were excluded from the study if they had previously received a diagnosis of leishmaniasis, had mucosal involvement, were pregnant or lactating, had received Sb V drugs for their current lesions, presented relative or absolute contraindication for the use of Sb V drugs (including a history of cardiac, renal, or hepatic disease), or had inappropriate localization of a cutaneous lesion or lymphatic region for direct xenodiagnosis (e.g., earlobe or eye).
Patients. Fifty-nine patients with active cutaneous leishmaniasis of р3 months of evolution who consulted the CID-EIM diagnostic facilities in Cali or the Hospital San Andres in Tumaco were enrolled in the study. Of these, 27 were available у13 weeks after the initiation of treatment for clinical evaluation and repeated sampling, to detect persistent infection. Sb V treatment and follow-up. After diagnosis and the completion of initial study procedures, meglumine antimoniate (Glucantime; Aventis Farma) was administered intramuscularly at a dosage of 20 mg/kg/day for 20 days, in accordance with Pan American Health Organization/World Health Organization and Colombian Ministry of Social Protection guidelines for the treatment of cutaneous leishmaniasis. Glucantime was supplied by the Colombian Ministry of Social Protection.
Initial therapeutic response was evaluated at у13 weeks after the initiation of treatment. Patients who experienced therapeutic failure-defined as an increase in legion size, the appearance of new lesions, incomplete epithelialization, and/or persistent signs of inflammation-before the 13th week were reevaluated clinically, and laboratory samples were obtained (by direct smear, culture of aspirate, or 4-mm-punch biopsy) to confirm the diagnosis and identify Leishmania species. Re-treatment with meglumine antimoniate was administered in accordance with national guidelines.
Study procedures. The procedures for the detection of the presence of Leishmania parasites before and after treatment are schematically summarized in figure 1. Normal skin sites were defined as those proximal to a path of lymphatic drainage, at a distance of 10-15 cm from a cutaneous lesion. Samples from scars were obtained after the completion of treatment (у13 weeks after the initiation of therapy) and only from patients who were deemed to be clinically cured.
Separation of monocytes. Monocytes were isolated and purified from 10 mL of human peripheral blood by use of NycoPrep (1.068 g/mL; Axis-Shield), in accordance with the manufacturer's instructions. After washing and centrifugation, the pellet (∼ -cells) was resuspended in 1000 mL 6 6 1.0 ϫ 10 2.0 ϫ 10 of Dulbecco's PBS (DPBS; Gibco-BRL); 100 mL was cultured in duplicate in Senekjie's diphasic culture medium for isolation of parasites, 300 mL (containing 300-600,000 monocytes) was used to artificially feed sand flies (indirect xenodiagnosis), and the rest (500 mL) was used to detect Leishmania parasites by molecular methods. For the latter, monocytes were centrifuged at 1300 g for 5 min, resuspended in 200 mL of DPBS, and frozen at Ϫ20ЊC until processed.
Direct xenodiagnosis. Two body sites were concomitantly evaluated: the border of an active lesion and a normal skin site. Both the lesion and the normal skin site were cleaned with 70% alcohol. Four 50-mL polystyrene tubes (Falcon) that were covered by a fine mesh and that contained 25 female sand flies (Lu. longipalpis) each were placed against the selected site. Feeding was allowed ad libitum for ∼30 min. After feeding, the insects were maintained at 26ЊC and 85%-90% humidity, exclusively on a sucrose diet. Five to seven days later, the insects were dissected to search for Leishmania promastigotes in the gut [13, 14] .
Indirect xenodiagnosis. Monocytes were used for artificial feeding with 100 female sand flies (Lu. longipalpis), as described by Ward et al. [19] . Approximately 300,000-600,000 cells were mixed with 2 mL of rabbit blood that had been inactivated at 56ЊC for 25 min and then placed in a vial covered with chickskin membrane; the flies were fed for 45 min. Under these experimental conditions, ∼75-150 human monocytes would be ingested by a fully engorged sand fly (р0.5 mL) during indirect xenodiagnosis, producing a concentration similar to that of monocytes in peripheral blood. Both methods of xenodiagnosis were performed before and after treatment.
Culture of dermal tissue fluid aspirates and monocytes. Dermal tissue fluid for culture and PCR was obtained as described elsewhere [20] . Dermal tissue fluid aspirates and peripheral-blood monocytes were inoculated into Senekjie's diphasic culture medium [20] .
PCR/Southern blot. Extraction of DNA and amplification of L. (Viannia) minicircle kinetoplast DNA (kDNA) from dermal tissue fluid aspirates and peripheral-blood monocytes before and after treatment were conducted as described elsewhere [21] . PCR was performed with the primers B1 (5 -GGG GTT GGT GTA ATA TAG TGG-3 ) and B2 (5 -CTA ATT GTG CAC GGG GAG G-3 ), which have been previously reported to specifically amplify the entire 750-bp minicircle kDNA of L.
(Viannia) species [22, 23] . To improve sensitivity and specificity, a chemiluminescent Southern blot was done at high stringency (65ЊC) on hybridized PCR products as described elsewhere [21] , using a probe comprising the 750-bp PCR product derived from L. panamensis kDNA in combination with the Alka-Phos Direct labeling and detection system and CDP-Star (Amersham-Pharmacia Biotech), in accordance with the manufacturer's instructions.
Identification of Leishmania species. Parasites isolated from skin lesions, normal skin, or scars were identified by indirect immunofluorescence with monoclonal antibodies [24] . Identification on the basis of isoenzyme polymorphisms was undertaken if strains could not be identified on the basis of reactivity with the panel of monoclonal antibodies [25] .
Statistical analyses. Statistical analyses were performed using SPSS for Windows (version 7.5; SPSS). Associations between frequencies of positive samples by biological and molecular methods and demographic and clinical characteristics of the patients from whom the samples were isolated were determined by use of contingency tables and the x 2 test. Relationships between the number of evaluable sand flies after xenodiagnosis (surviving, engorged specimens) and the acquisition of infection were examined by use of the Kruskal-Wallis test followed by the Dunn procedure.
was considered P ! .05 to be statistically significant.
RESULTS
The 59 patients were predominantly males of African or mestizo ethnicity and were between 16 and 55 years of age (table 1) . The majority resided in areas where leishmaniasis transmission was endemic. Regional adenopathy was detected in 45 (76.3%) of the patients at diagnosis (table 1) . Twenty-seven patients (45.8%) provided samples at follow-up as well as before treatment; the demographic characteristics of these patients were similar to those of the patients who were unavailable for followup ( Direct biological evidence of the infectiousness of patient lesions before treatment was obtained for 5 (8.8% [95% CI, 2.9%-19.3%]) of 57 patients who transmitted parasites to sand flies that fed on the lesion border. Direct xenodiagnosis before treatment and indirect xenodiagnosis (by artificial feeding) at follow-up was negative for normal skin and healed lesions. The number of sand flies that fed during xenodiagnosis varied from 2 to 190. A significantly larger number of sand flies fed on lesion borders than on normal skin or healed lesions ( ). P ! .05 Notably, xenodiagnosis was positive only when у50 sand flies had engorged ( ) (table 3) , and the proportion of pos-P ! .001 itive results increased to 31.3% (5/16) when at least 50 sand flies had fed and survived for evaluation. In addition, Leishmania parasites were cultured from 2 (3.6% [95% CI, 0.4%-12.5%]) of 55 dermal tissue fluid aspirates obtained from unaffected skin during active disease.
DISCUSSION
The increasing importance of domestic transmission of cutaneous leishmaniasis [1, 26, 27] and clinical treatment failure due, at least in part, to drug-resistant parasites [12] support the plausibility of humans as reservoirs of Leishmania parasites. Evidence that humans can act as a reservoir of New World leishmaniases is limited to xenodiagnosis of patients and seropositive inhabitants of an area in Brazil where L. chagasi transmission is endemic [28] and to anecdotal reports of xenodiagnosis on the border of cutaneous lesions: in Venezuela, L. braziliensis using the natural vector Lu. youngi [29] ; in Brazil, L. amazonensis using the surrogate vector Lu. longipalpis but not L. braziliensis using either Lu. longipalpis or its natural vector, Lu. intermedia [30] ; and in Colombia, L. panamensis using Lu. longipalpis [14] . However, several studies have detected the presence of live L. (Viannia) parasites in blood [16] and in scars [17] even several years after healing, and Leishmania DNA has been amplified from peripheral-blood cells and from scars [15, 31, 32] . The present study was designed to demonstrate the availability of L. (Viannia) parasites in tissues accessible to sand flies in the human host. The results show that at least 44% of patients with cutaneous leishmaniasis present molecular and/ or parasitological evidence of Leishmania parasites in blood, normal skin, or healed lesions, in addition to the active lesion. Treatment did not diminish the overall rate of positivity. However, biological methods did not yield parasites in the 22 patients evaluated after treatment. The low sensitivity of the biological methods as used and the reduced number of patients available for evaluation after treatment do not allow conclusions to be drawn about the impact that treatment has on infectivity.
Remarkably, Leishmania parasites were detected in normal skin before (7.5%) and after (13.6%) treatment by molecular methods and were also cultured from the normal skin of 2 patients before treatment, hence proving that viable parasites are present in normal skin, not only in the lesion. To our knowledge, this is the first demonstration of L. (Viannia) parasites in normal skin, supporting the notion that these parasites are available in the unaffected skin of individuals with active disease. Together with the frequent presence of Leishmania DNA in peripheral-blood monocytes before and after treatment, the demonstration of parasites in extralesional tissues shows that L. (Viannia) parasites circulate throughout the body during active disease and after the clinical resolution of lesions.
Five patients (8.6%) had positive xenodiagnostic results before treatment. In light of the small number of sand flies that fed on the lesion borders and normal skin of individual patients during two 30-min intervals, compared with the permanent exposure to sand-fly bites in endemic foci of transmission, our results provide a minimal estimate of the "infectiousness" of patients for sand flies. Children with L. chagasi infection in Brazil have been found to be 11 times more infectious for sand flies than adults [28] . As in L. chagasi transmission, L. (Viannia) infection is more likely to cause disease in children than in adults-that is, they are more susceptible [33] . In consequence, the exclusion of children from this study (because of concern about tolerability) is likely to have contributed to an underestimation of the ability of the affected human population to infect sand flies, particularly in circumstances of peri-and intradomiciliary transmission, where they constitute a large and growing proportion of patients.
Xenodiagnostic experiments conducted in dogs have shown that individual hosts vary in infectiousness; a few (7/42) infected dogs proved to be highly infectious, accounting for 180% of the sand-fly infections, whereas others did not infect sand flies under the experimental conditions used [34] . PCR and culture of seropositive blood donors from an area in which L. infantum/chagasi transmission was endemic have demonstrated intermittent parasitemia in asymptomatically infected individuals [35] [36] [37] . Hence, although parasitemia may be more frequently demonstrable in symptomatic patients or dogs, asymptomatically infected individuals are also a plausible source of infection [9, 38] .
The use of a species of sand fly that is a natural vector of the L. (Viannia) subgenus as well as engorgement of a larger number of sand flies might improve the sensitivity of xenodiagnosis. Xenodiagnosis of L. braziliensis was achieved before treatment in 8 patients by feeding 25-50 Lu. youngi, a natural vector of this species in Venezuela, on the borders of lesions of 1-3 months' duration [28] . An impressive 3.6%-19.2% of flies became infected [28] . In the present study, positive xenodiagnosis was only achieved when at least 50 sand flies had fed and survived until evaluation 5 days later. If we considered in the analysis only patients from whom у50 sand flies were available for evaluation after the flies had been fed on the lesion border, the proportion of positive xenodiagnostic results increased to 31.3% (5/16). Fifty or more sand flies were available for evaluation after xenodiagnosis on normal skin or after artificial feeding on monocytes for very few patients either before (6 and 4 patients, respectively) or after (0 and 3 patients, respectively) treatment (table 3) . Therefore, the sensitivity of the xenodiagnostic procedure for normal skin and monocytes or for healed lesions was not comparable with that of the xenodiagnostic procedure for lesion borders, and, consequently, the results with regard to the infectivity of patients after treatment are inconclusive. The reason that sand flies fed more readily when exposed to lesion borders than to unaffected skin is unknown. However, because parasite burden and the density of inflammatory mononuclear cells harboring parasites are likely to be higher at the lesion border, a preference for feeding on or near lesions in nature would favor acquisition of infection.
Molecular methods for the detection of genetic material have proven to be more sensitive than biological methods for the detection of Leishmania parasites themselves [39, 40] . Consequently, such methods are largely replacing less sensitive parasitological strategies for investigating the natural history and epidemiology of leishmaniasis and other transmissible diseases. In the present evaluation of the presence and availability of Leishmania parasites to sand-fly vectors, the specificity and enhanced sensitivity of PCR coupled with DNA hybridization demonstrated in a previous study [21] was verified-the presence of Leishmania parasites was detected at a higher frequency (21/59 [35.6%] ) by this method than by all biological methods combined (7/59 [11.9%] ). Although the molecular-detection method used establishes only the presence of parasite DNA, a study of the diagnosis of Chlamydia infection showed that the presence of DNA was associated with the presence of live bacteria and that DNA usually disappeared within 24 h or a maximum of 1 week after bacterial death [41] . Furthermore, in another study, Leishmania DNA levels in blood fell below the limits of detection by PCR in 16 of 17 cases of visceral leishmaniasis within 37 days after the initiation of treatment and, hence, provided an indicator of therapeutic response in visceral leishmaniasis caused by L. chagasi infection [42] . Therefore, the presence of Leishmania kDNA in blood and dermal tissue fluid у13 weeks after the initiation of treatment for cutaneous leishmaniasis is likely to indicate the presence of viable parasites. Nevertheless, methods such as real-time PCR targeting RNA should be used to confirm the presence of live parasites [43] .
Notably, only 2 of 10 patients in whom Leishmania kDNA was detected in skin, scars, or monocytes after treatment had clinical treatment failure. The ED 50 of Sb V for strains isolated before treatment as well as at treatment failure in one of these patients (3565) was 1128 mg Sb V /mL, indicating insensitivity to Sb drugs. Regardless of clinical outcome, parasites that persist after treatment have potential importance in the propagation of drug resistance, given that we have recently documented that standard treatment of American cutaneous leishmaniasis caused by L. (Viannia) infection can indeed select for resistance [12] . Diminished sensitivity to Sb drugs associated with previous treatment has also been documented in dogs; strains isolated from treated dogs were 8-41 times less susceptible to Sb drugs than were those isolated from the same dogs before treatment [44] . The documentation of both primary and secondary resistance in clinical strains [12] is consistent with the persistence and accumulation of parasites with diminished drug sensitivity in endemically exposed human populations. Our results show that L. (Viannia) parasites are present in sites other than the lesion and that they persist in tissues available to sand flies after successful treatment in a substantial proportion of patients. The proportion of positive patients varied by method and sample type: although 11.9% of patients yielded live parasites by either culture of normal skin or xenodiagnosis of lesion border before treatment, 22.8% and 25.9% presented PCR/Southern blot evidence of Leishmania parasites in normal skin or blood monocytes before and after treatment, respectively (table 2) . In light of the high number and proportion of infected individuals in areas of endemicity, the plausibility that humans play an important role in the transmission of L. (Viannia) parasites is compelling. The accumulation of observations made over decades indicate that patients with cutaneous leishmaniasis can harbor Leishmania parasites indefinitely and that no currently available treatment completely eliminates them [45] . This fact is particularly relevant to the recent detection of highly anthropophilic Lutzomyia species in urban and periurban areas of Venezuela [46] , Brazil [47] , Bolivia, and Peru [1, 48, 49] . We believe that the present results, together with these previous findings, call for a reassessment of the role played by humans in transmission cycles of New World cutaneous leishmaniasis, of control strategies, and of the impact that treatment has on transmission.
corcia, for identification of species and strains by monoclonal-antibody typing.
